IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
Recruiting · NCT05994131 · Registry updated 2025-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC | non-small cell lung carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-04-30 | NCT05994131 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InxMed (Shanghai) Co., Ltd. | 10 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Pulmonary Hospital | Shanghai | China | 33 |